Get started
China Resources Pharmaceutical Group Ltd.China Resources Pharmaceutical Group Ltd.China Resources Pharmaceutical Group Ltd.

China Resources Pharmaceutical Group Ltd.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2025
Earnings, H2 FY2025
Annual
Mar 24, 2026
Net profit up 14.9% on 4.6% revenue growth, with improved margins and higher dividend.
Earnings, H1 FY2025
Aug 27, 2025
Revenue up 2.5% YoY, net profit down 8.8%, interim dividend RMB0.072 per share.
2024
Earnings, H2 FY2024
Annual
Mar 26, 2025
Revenue and net profit rose, with strong manufacturing and distribution growth and higher margins.
Earnings, H1 FY2024
Aug 30, 2024
Revenue and net profit rose, with strong segment growth and first-ever interim dividend declared.
2023
Earnings, H2 FY2023
Annual
Mar 26, 2024
Earnings, H1 FY2023
Aug 31, 2023
2022
Earnings, H2 FY2022
Annual
Mar 30, 2023
Earnings, H1 FY2022
Aug 25, 2022
2021
Earnings, H2 FY2021
Annual
Mar 29, 2022
Earnings, H1 FY2021
Aug 25, 2021
2020
Earnings, H2 FY2020
Annual
Apr 22, 2021
2019
Earnings, H2 FY2019
Annual
Apr 21, 2020
2018
Earnings, H2 FY2018
Annual
Apr 18, 2019
2017
Earnings, H2 FY2017
Annual
Apr 17, 2018
2016
Earnings, H2 FY2016
Annual
Apr 11, 2017